These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 33477103)

  • 41. ASPIRE In-Home: rationale, design, and methods of a study to evaluate the safety and efficacy of automatic insulin suspension for nocturnal hypoglycemia.
    Klonoff DC; Bergenstal RM; Garg SK; Bode BW; Meredith M; Slover RH; Ahmann A; Welsh JB; Lee SW
    J Diabetes Sci Technol; 2013 Jul; 7(4):1005-10. PubMed ID: 23911183
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Delayed prandial insulin boluses are an important determinant of blood glucose control and relate to fear of hypoglycemia in people with type 1 diabetes on advanced technologies.
    Annuzzi G; Triggiani R; De Angelis R; Rainone C; Corrado A; Scidà G; Lupoli R; Bozzetto L
    J Diabetes Complications; 2024 Feb; 38(2):108689. PubMed ID: 38244326
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of mild-to-moderate hypoglycemia in patients with type 1 diabetes treated with insulin pump therapy: are current recommendations effective?
    Gingras V; Desjardins K; Smaoui MR; Savard V; Messier V; Haidar A; Legault L; Rabasa-Lhoret R
    Acta Diabetol; 2018 Mar; 55(3):227-231. PubMed ID: 29224132
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Insulin Sensitivity Index-Based Optimization of Insulin to Carbohydrate Ratio: In Silico Study Shows Efficacious Protection Against Hypoglycemic Events Caused by Suboptimal Therapy.
    Schiavon M; Dalla Man C; Cobelli C
    Diabetes Technol Ther; 2018 Feb; 20(2):98-105. PubMed ID: 29355438
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Insulin-based strategies to prevent hypoglycaemia during and after exercise in adult patients with type 1 diabetes on pump therapy: the DIABRASPORT randomized study.
    Franc S; Daoudi A; Pochat A; Petit MH; Randazzo C; Petit C; Duclos M; Penfornis A; Pussard E; Not D; Heyman E; Koukoui F; Simon C; Charpentier G
    Diabetes Obes Metab; 2015 Dec; 17(12):1150-7. PubMed ID: 26264812
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of the Sensor-Augmented Pump System with the Advanced Hybrid Closed-Loop Delivery System: Quality of Life, Diabetes Distress, and Glycaemic Outcomes in a Real-Life Context.
    Benioudakis ES; Karlafti E; Kalaitzaki A; Kalpou MA; Georgiou ED; Savopoulos C; Didangelos T
    Curr Diabetes Rev; 2024; 20(3):e310523217505. PubMed ID: 37259938
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of frequency of sensor use on glycaemic control in individuals on sensor-augmented pump therapy with and without Predictive Low Glucose Management System.
    Abraham MB; Smith GJ; Nicholas JA; Fairchild JM; King BR; Ambler GR; Cameron FJ; Davis EA; Jones TW;
    Diabetes Res Clin Pract; 2020 Jan; 159():107989. PubMed ID: 31866529
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Closed-Loop Control of Postprandial Glycemia Using an Insulin-on-Board Limitation Through Continuous Action on Glucose Target.
    Rossetti P; Quirós C; Moscardó V; Comas A; Giménez M; Ampudia-Blasco FJ; León F; Montaser E; Conget I; Bondia J; Vehí J
    Diabetes Technol Ther; 2017 Jun; 19(6):355-362. PubMed ID: 28459603
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Switching from Suspend-Before-Low Insulin Pump Technology to a Hybrid Closed-Loop System Improves Glucose Control and Reduces Glucose Variability: A Retrospective Observational Case-Control Study.
    Lepore G; Scaranna C; Corsi A; Dodesini AR; Trevisan R
    Diabetes Technol Ther; 2020 Apr; 22(4):321-325. PubMed ID: 31617752
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Extended Use of an Open-Source Automated Insulin Delivery System in Children and Adults with Type 1 Diabetes: The 24-Week Continuation Phase Following the CREATE Randomized Controlled Trial.
    Burnside MJ; Lewis DM; Crocket HR; Meier RA; Williman JA; Sanders OJ; Jefferies CA; Faherty AM; Paul RG; Lever CS; Price SKJ; Frewen CM; Jones SD; Gunn TC; Lampey C; Wheeler BJ; de Bock MI
    Diabetes Technol Ther; 2023 Apr; 25(4):250-259. PubMed ID: 36763345
    [No Abstract]   [Full Text] [Related]  

  • 51. Multinational Home Use of Closed-Loop Control Is Safe and Effective.
    Anderson SM; Raghinaru D; Pinsker JE; Boscari F; Renard E; Buckingham BA; Nimri R; Doyle FJ; Brown SA; Keith-Hynes P; Breton MD; Chernavvsky D; Bevier WC; Bradley PK; Bruttomesso D; Del Favero S; Calore R; Cobelli C; Avogaro A; Farret A; Place J; Ly TT; Shanmugham S; Phillip M; Dassau E; Dasanayake IS; Kollman C; Lum JW; Beck RW; Kovatchev B;
    Diabetes Care; 2016 Jul; 39(7):1143-50. PubMed ID: 27208316
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sustained efficacy of continuous subcutaneous insulin infusion in type 1 diabetes subjects with recurrent non-severe and severe hypoglycemia and hypoglycemia unawareness: a pilot study.
    Giménez M; Lara M; Conget I
    Diabetes Technol Ther; 2010 Jul; 12(7):517-21. PubMed ID: 20597825
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relation Between Hypoglycemia and Glycemic Variability in Type 2 Diabetes Patients with Insulin Therapy: A Study Based on Continuous Glucose Monitoring.
    Uemura F; Okada Y; Torimoto K; Tanaka Y
    Diabetes Technol Ther; 2018 Feb; 20(2):140-146. PubMed ID: 29293363
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevention of nocturnal hypoglycemia using predictive alarm algorithms and insulin pump suspension.
    Buckingham B; Chase HP; Dassau E; Cobry E; Clinton P; Gage V; Caswell K; Wilkinson J; Cameron F; Lee H; Bequette BW; Doyle FJ
    Diabetes Care; 2010 May; 33(5):1013-7. PubMed ID: 20200307
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prospective Analysis of the Impact of Commercialized Hybrid Closed-Loop System on Glycemic Control, Glycemic Variability, and Patient-Related Outcomes in Children and Adults: A Focus on Superiority Over Predictive Low-Glucose Suspend Technology.
    Beato-Víbora PI; Gallego-Gamero F; Lázaro-Martín L; Romero-Pérez MDM; Arroyo-Díez FJ
    Diabetes Technol Ther; 2020 Dec; 22(12):912-919. PubMed ID: 31855446
    [No Abstract]   [Full Text] [Related]  

  • 57. Health-related quality of life and treatment satisfaction in the Sensor-Augmented Pump Therapy for A1C Reduction 3 (STAR 3) trial.
    Rubin RR; Peyrot M;
    Diabetes Technol Ther; 2012 Feb; 14(2):143-51. PubMed ID: 22133037
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Real-world effectiveness and safety of sensor-augmented insulin pump therapy in adults with type 1 diabetes: Long-term follow-up.
    Coronel-Restrepo N; Blanco VM; Palacio A; Ramírez-Rincón A; Arbeláez S; Duque V; Pino JJ; Carvajal J; Bedoya J; Cuesta DP; Botero JF
    Endocrinol Diabetes Nutr (Engl Ed); 2021 Oct; 68(8):567-572. PubMed ID: 34872640
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reducing Hypoglycemia in the Real World: A Retrospective Analysis of Predictive Low-Glucose Suspend Technology in an Ambulatory Insulin-Dependent Cohort.
    Müller L; Habif S; Leas S; Aronoff-Spencer E
    Diabetes Technol Ther; 2019 Sep; 21(9):478-484. PubMed ID: 31329468
    [No Abstract]   [Full Text] [Related]  

  • 60. Hypoglycemia Incidence and Factors Associated in a Cohort of Patients With Type 2 Diabetes Hospitalized in General Ward Treated With Basal Bolus Insulin Regimen Assessed by Continuous Glucose Monitoring.
    Gómez AM; Imitola Madero A; Henao Carrillo DC; Rondón M; Muñoz OM; Robledo MA; Rebolledo M; García Jaramillo M; León Vargas F; Umpierrez G
    J Diabetes Sci Technol; 2020 Mar; 14(2):233-239. PubMed ID: 30678495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.